SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fattovich G, Tagger A, Brollo L et al. Hepatitis C virus infection in chronic hepatitis B carriers. J. Infect. Dis. 1991; 163: 4002.
  • 2
    Pontisso P, Ruvoletto MG, Fattovich G et al. Clinical and virological profiles in patients with multiple hepatitis infections. Gastroenterology 1993; 105: 152933.
  • 3
    Sato S, Shigetoshi F, Tanaka M et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J. Hepatol. 1994; 21: 15966.
  • 4
    Crespo J, Lozano JL, De La Cruz F et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am. J. Gastroenterol. 1994; 89: 114751.
  • 5
    Zarski J-P, Bohn B, Bastie A et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J. Hepatol. 1998; 28: 2733.
  • 6
    Buti M, Costa X, Valdes A et al. Study of hepatitis B virus replication and infection by other hepatitis viruses in patients with chronic hepatitis B virus infection. Gastroenterologia Y. Hepatologia 2002; 25: 2958 (in Spanish).
  • 7
    Gaeta GB, Stornaiuolo G, Precone DF et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J. Hepatol. 2003; 39: 103641.
  • 8
    Weltman MD, Brotodihardjo A, Crewe EB et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and respond poorly to interferon-alpha treatment. J. Viral Hepatol. 1995; 2: 3945.
  • 9
    Shiratori Y, Shiina S, Zhang PY et al. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997; 80: 20607.
  • 10
    Mazzella G, Saracco G, Festi D et al. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am. J. Gastroenterol. 1999; 94: 224650.
    Direct Link:
  • 11
    Chiaramonte M, Stroffolini T, Vian A et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 21327.
  • 12
    Sagnelli E, Coppola N, Scolastico C et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000; 32: 110610.
  • 13
    Squadrito G, Orlando ME, Pollicino T et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am. J. Gastroenterol. 2002; 97: 151823.
    Direct Link:
  • 14
    Raimondo G, Pollicino T, Squadrito G. Clinical virology of hepatitis B virus infection. J. Hepatol. 2003; 39 (Suppl. 1): S26S30.
  • 15
    Liaw XF, Chien RN, Lin SM et al. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J. Interf. Cytok. Res. 1997; 17: 44952.
  • 16
    Guptan RC, Thakur V, Raina V, Sarin SK. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J. Gastroenterol. Hepatol. 1999; 14: 8938.
  • 17
    Villa E, Grottola A, Buttafoco P et al. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am. J. Gastroenterol. 2001; 96: 29737.
  • 18
    Liu CJ, Chen PJ, Lai MY et al. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology 2003; 37: 56876.
  • 19
    Hung CH, Lee CM, Lu SN et al. Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J. Gastroenterol. Hepatol. 2005; 20: 72732.
  • 20
    Villa E, Grottola A, Trande P et al. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, anti-HCV-positive patients. Lancet 1993; 341: 1413.